Angiotensinogen (Ao) is the obligatory glycoprotein substrate for the enzymatic generation of the angiotensin peptides. There are high concentrations of Ao in plasma, originating mostly from hepatic biosynthesis. Numerous additional tissues which, among others, include the heart, adrenal, kidney, pituitary and brain, also express Ao [1] . The Ao synthesized by these tissues is available for the local generation of angiotensins. Consequently, changes in the availability of Ao via regulation of its synthesis and secretion is likely to directly affect the activity of local angiotensin-generating systems.
Regulation of Ao by glucocorticoids (GCs) has been investigated mostly for liver where secretion and mRNA content increase several-fold [2-4]. However, sensitivity to GCs is tissuespecific and has been particularly difficult to show in brain tissue [3, 5, 6 ]. In addition, it has been demonstrated in the liver that GCs interact additively with cAMP and permissively with interleukins [2, 4]. Recently we reported an inhibitory action of GC in C6 glioma cells which could be prevented by cAMP and isoprenaline [7] . Since GCs and cAMP are known to interact negatively or positively in gene expression, depending on tissue [8, 9] , it is possible that the range of GC sensitivities reported for Ao results from tissue specific interactions with cAMP or with some other factor. We report recent data in which cell cultures of H4 (rat hepatoma) and primary cultures of pituitary, astrocyte and neuronal cells were used to investigate the interaction of the glucocorticoid, dexamethasone (DEX) with cAMP.
Methods
Rat H4 hepatoma cells were cultured as described previously [7, 10] . One day before experiments, the medium was changed to a serum-free formula supplemented with ITS (5 mg/ml insulin, 5 mg/transferrin, 5 ng/ml selenite). Pituitary cells were obtained from adrenalectomized male Wistar rats; neuronal cells from neonates and glial cells were from 21-day-old Sprague-Dawley rats [6, 10] . Ao in the culture medium was measured by a direct (Fig. 1A ). The addition of 1 mri dibutyryl cAMP increased the mean secretion by 340% compared to that with Dex alone. Increasing the concentrations of dBcAMP in the absence of Dex also increased secretion up to, but not above 2 mvi dBcAMP (Fig. 1B) . Altering intracellular cAMP via the beta-adrenoceptor agonist isoprenaline (0.1 j.LM) or the alpha agonist 6-FNA (0.1 LM) had no effect on either basal or DEXstimulated secretion (data not shown). Primary pituitary cells prepared from adrenalectomized rats were markedly responsive to increasing concentrations of DEX, with a pronounced 20-fold increase from 2.9 0.6 (control) to 57.7 5.6 ng Ao/106 cells/3 days at 0.1 M DEX (Fig. 2A) . The addition of 1 m'vi dBcAMP increased the mean secretion by 400% compared to that with Dex alone. The Ao mRNA of the (1 .LM Dex + 1 mM dBcAMP) group was 38-fold above the control (which was assigned a density of 1), as measured by RT-PCR (Fig. 2B) . However, neither isoprenaline nor 6-FNA significantly changed basal or DEX-stimulated secretion. Preparations of glia from 21-day-old rat brains did not respond to DEX, dBcAMP or a combination of both (Fig. 3A) . Neuronal cells from one-day-old rat brains increased Ao secretion by only 2.5-fold; dBcAMP had no effect (Fig. 3B) . found the accumulation of Ao mRNA by cAMP and Dex to be been reported for the regulation of nerve growth factor [11] . We additive, while our secretion data suggest a factorial synergism recently found an inhibitory action of Dex in glioma cells which (Fig. 1) , which is also supported by the RT-PCR data for the was antagonized by cAMP [7] , suggesting that GC regulation of pituitary (Fig. 2) . It is noteworthy that we could not reproduce the Ao may include inhibitory as well as stimulatory actions, as 
